{
  "compound": "CBD oral",
  "condition": "ARTHRITIS",
  "effect_size": "Large (Cohen's d = 1.08)",
  "study_type": "RCT",
  "source": "NORML:ARTHRITIS_RCT_009",
  "participants": "196 adults with symptomatic hip OA (ACR criteria)",
  "year": 2021,
  "notes": "Cannabidiol for Osteoarthritis Hip Pain: A Multicenter RCT",
  "confidence": "medium",
  "abstract": "CBD: 46% reduction in WOMAC pain (14.2 \u2192 7.7); Placebo: 19% reduction (14.0 \u2192 11.3); p<0.001"
}